Home › Pancreatic Ductal Carcinoma › Texas › San Antonio
Pancreatic Ductal Carcinoma clinical trials in San Antonio, TX
3 studies for Pancreatic Ductal Carcinoma are looking for participants at sites in and around San Antonio (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma
RecruitingPhase 2
- Site 01, San Antonio
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RecruitingPhase 1/2
- NEXT Oncology San Antonio, San Antonio
- START Texas, San Antonio
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
RecruitingPhase 1/2
- Next Oncology, San Antonio
Pancreatic Ductal Carcinoma trials in other cities
- Boston, MA4 studies
- Nashville, TN4 studies
- Scottsdale, AZ3 studies
- Arlington, VA3 studies
- Tampa, FL3 studies
- Orange, CA3 studies
- New York City, NY3 studies
- Houston, TX3 studies
- Cincinnati, OH3 studies
Other studies in San Antonio
- Non-Small Cell Lung Cancer59 studies
- Breast Cancer47 studies
- Colorectal Cancer46 studies
- Metastatic Cancer44 studies
- Cancer (all types)41 studies
- Obesity40 studies
- Type 2 Diabetes37 studies
- Overweight34 studies
- Ovarian Cancer31 studies
- Pancreatic Cancer31 studies
- Prostate Cancer28 studies
- Endometrial Cancer27 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.